These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15563849)

  • 1. Life with consequences of breast cancer: pregnancy during and after endocrine therapies.
    Goldhirsch A; Gelber RD
    Breast; 2004 Dec; 13(6):443-5. PubMed ID: 15563849
    [No Abstract]   [Full Text] [Related]  

  • 2. Tamoxifen and pregnancy.
    Barthelmes L; Gateley CA
    Breast; 2004 Dec; 13(6):446-51. PubMed ID: 15563850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.
    Parton M; Smith IE
    J Clin Oncol; 2008 Feb; 26(5):745-52. PubMed ID: 18258982
    [No Abstract]   [Full Text] [Related]  

  • 4. Endocrine therapy and other targeted therapies for metastatic breast cancer.
    Hussain SA; Palmer DH; Moon S; Rea DW
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1179-95. PubMed ID: 15606341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
    Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
    [No Abstract]   [Full Text] [Related]  

  • 6. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
    McCaul KA
    Obstet Gynecol; 2005 Jan; 105(1):217-8; author reply 218-9. PubMed ID: 15625169
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of tamoxifen before and during pregnancy.
    Braems G; Denys H; De Wever O; Cocquyt V; Van den Broecke R
    Oncologist; 2011; 16(11):1547-51. PubMed ID: 22020212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen-induced radiation recall dermatitis.
    Kundranda MN; Daw HA
    Am J Clin Oncol; 2006 Dec; 29(6):637-8. PubMed ID: 17149005
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women.
    Mouridsen HT
    Curr Med Res Opin; 2006 Aug; 22(8):1609-21. PubMed ID: 16870085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer.
    Sawada S; Sato K; Kusuhara M; Ayaori M; Yonemura A; Tamaki K; Hiraide H; Mochizuki H; Ohsuzu F
    Acta Oncol; 2005; 44(2):134-41. PubMed ID: 15788292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen-induced ultraviolet, recall dermatitis.
    Ledet JJ; Grafton LH
    J Drugs Dermatol; 2009 Aug; 8(8):761-2. PubMed ID: 19663115
    [No Abstract]   [Full Text] [Related]  

  • 12. Tales from a targeted therapy.
    Elledge RM
    J Clin Oncol; 2006 Mar; 24(9):1323-5. PubMed ID: 16505410
    [No Abstract]   [Full Text] [Related]  

  • 13. Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients--design and baseline data 'LIBERATE' trial.
    Kenemans P; Kubista E; Foidart JM; Yip CH; von Schoultz B; Sismondi P; Vassilopoulou-Sellin R; Beckmann MW; Bundred NJ; Egberts J; van Os S; Planellas J
    Breast; 2007 Dec; 16 Suppl 2():S182-9. PubMed ID: 17983942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Additional effect of SERM: mammary gland].
    Kurebayashi J
    Clin Calcium; 2004 Oct; 14(10):47-51. PubMed ID: 15577131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report.
    Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G
    Int J Gynecol Pathol; 2006 Apr; 25(2):173-5. PubMed ID: 16633068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic behavior of endometrial hyperplasia during tamoxifen therapy for breast cancer.
    Garuti G; Cellani F; Centinaio G; Sita G; Nalli G; Luerti M
    Gynecol Oncol; 2006 May; 101(2):269-73. PubMed ID: 16297970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen.
    Nurs Times; 2006 Feb 21-27; 102(8):33. PubMed ID: 16519033
    [No Abstract]   [Full Text] [Related]  

  • 19. Macroautophagy inhibition sensitizes tamoxifen-resistant breast cancer cells and enhances mitochondrial depolarization.
    Qadir MA; Kwok B; Dragowska WH; To KH; Le D; Bally MB; Gorski SM
    Breast Cancer Res Treat; 2008 Dec; 112(3):389-403. PubMed ID: 18172760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK; Nielsen DL; Lindberg H; Kamby C
    Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.